
“The U.S. Supreme Court ruled on Monday that makers of generic drugs already approved by the U.S. Food and Drug Administration cannot be held liable under state law for claims of design defects. In a 5-4 vote, the court ruled for Mutual Pharmaceutical Co, a unit of URL Pharma, owned by Sun Pharmaceutical Industries.”
Related posts:
Fitch: rising delinquency rates pose looming threat for FHA
Smackdown: Glenn Greenwald versus Mika Brzezinski
India Sets Norms to Open $20 Billion REIT Market
How did a modern feminist become a brutal dictator's wife?
New York ‘soccer mom’ accused of $3 million marijuana operation
New Zealand passes law allowing domestic surveillance
The Washington Post sold to Amazon founder Jeff Bezos
No trace of Sandy Hook Elementary School will be left
Russian central bank to keep buying gold
Overstock CEO: Why we're accepting bitcoins
Police summoned, multiple schools locked down after man spotted carrying umbrella
Der Spiegel: Public Must Fight against Prism and Tempora Surveillance
Syria, Iran issue first explicit warning to Israel if US attacks
Utah Uses Eminent Domain to Seize Land of ... Uncle Sam
Dutch woman arrested for ‘recruiting Syrian jihadists’ to fight alongside rebels